Showing results (71-80 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|February 3, 2022
Investigation of the effects of the toll-like receptor 4 pathway on immune checkpoint vista in pancreatic cancerKubra Sena Bas Topcu, Emine Nedime Korucu, Esma Menevse, et al.Investigational New Drugs|February 12, 2022
The 45-month therapy outcomes of permanent seed implantation and radical prostatectomy for prostate cancer patientsChao Li, Mengdong Zhang, Jianwen Wang, et al.Investigational New Drugs|April 11, 2022
A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancersHui K Gan, Sagun Parakh, F T Lee, et al.Investigational New Drugs|April 11, 2022
Practical consideration for successful sequential tumor biopsies in first-in-human trialsTakafumi Koyama, Toshio Shimizu, Jun Sato, et al.Investigational New Drugs|April 19, 2022
Effects of Nivolumab and Ipilimumab on the suppression of cisplatin resistant small cell lung cancer cellsWei Chi, Lianyong Zhang, Xue Wang, et al.Investigational New Drugs|January 1, 1986
Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cellsR T Dorr, J D Liddil, M J SobleInvestigational New Drugs|April 28, 2022
Exportin-1 is critical for cell proliferation and survival in adult T cell leukemiaChie Ishikawa, Naoki MoriInvestigational New Drugs|January 1, 1985
Phase I-II trial of mitoxantrone in acute leukemia: an interim reportZ A Arlin, G Dukart, I Schoch, et al.Investigational New Drugs|January 1, 1985
A phase II trial of aclacinomycin-A in advanced squamous cell carcinoma of the head and neckJ L Eckenrode, R H Wheeler, A A ForastiereInvestigational New Drugs|February 28, 2022
IL-10 contributes to gemcitabine resistance in extranodal NK/T-cell lymphoma cells via ABCC4Jia Huo, Lijun Fu, Mengyuan Jin, et al.Pageof 372